Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Netherlands-based biotech company ProteoNic has signed a commercial license agreement with Oxford Expression Technologies (OET) to extend its partnership.
Subscribe to our email newsletter
As per the new agreement, OET will gain the rights to use ProteoNic’s UNic translation enhancing elements in its flashBAC system for third party recombinant protein production services.
ProteoNic will provide technical support under the agreement. The financial terms of the deal include upfront and royalty payments.
As part of the previous collaboration, both the companies have combined ProteoNic’s UNic translation enhancing technology with OET’s flashBAC system to improve recombinant protein yields in insect cells.
OET sales manager Rory Woodhouse said the combination of the UNic technology and the flashBAC expression system has already shown to have a positive effect on eukaryotic protein expression.
"This new agreement will enable us to build on our partnership and experience with ProteoNic, working together to provide a superior platform for our customers with more challenging to express proteins," Woodhouse added.